Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

References

• Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182(5A Suppl):11-18S.
   PubMed Web of Science ®Google Scholar
• Bell T, Panchal SJ, Miaskowski C, The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 2009;10:35-42.
   PubMed Web of Science ®Google Scholar
• Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63:649-71.
   PubMed Web of Science ®Google Scholar
• Shahbazian A, Heinemann A, Schmidhammer H, Involvement of μ- and κ-, but not δ-opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea pig intestine. Br J Pharmacol 2002;135:741-50.
   PubMed Web of Science ®Google Scholar
• De Luca A, Coupar IM. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996;69:103-15.
   PubMed Web of Science ®Google Scholar
• Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004;16(Suppl 2):17-28.
   PubMedGoogle Scholar
• Manara L, Bianchi G, Ferretti P, Tavani A. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther 1986;237:945-9.
   PubMed Web of Science ®Google Scholar
• Grider JR, Makhlouf GM. Role of opioid neurons in the regulation of intestinal peristalsis. Am J Physiol Gastrointest Liver Physiol 1987;253:G226-31.
   PubMed Web of Science ®Google Scholar
• Wirz S, Wartenberg HC, Wittman M. Post-operative pain therapy with controlled release tramadol following orthopedic surgery: a prospective, randomized, double-blind investigation. Pain Clinic 2005;17:367-76.
   Google Scholar
• Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 2002;23:48-53.
   PubMed Web of Science ®Google Scholar
• Avila JG. Pharmacological treatment of constipation in cancer patients. Cancer Control 2004;11(Suppl 1):10-18.
   PubMedGoogle Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life. The remarkable university of half a standard deviation. Med Care 2003;41:582-92.
   PubMed Web of Science ®Google Scholar
• Bates JJ, Foss JF, Murphy DB. Are peripheral opioid antagonists the solution to opioid side effects? Anesth Analg 2004;98:116-22.
   PubMed Web of Science ®Google Scholar
• Paulson D, Kennedy DT, Donovick RA, Alvimopan: an oral, peripherally acting μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction – a 21 day treatment-randomized clinical trial. J Pain 2005;6:184-92.
   PubMed Web of Science ®Google Scholar
• Holzer P. New approaches to the treatment of opioid-induced constipation. Eur Rev Med Pharmacol Sci 2008;12(Suppl 1):119-27.
   PubMedGoogle Scholar
• Holzer P. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett 2004;361:192-5.
   PubMed Web of Science ®Google Scholar
• Meissner W, Leyendecker P, Müller-lissner S, A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009;13:56-64.
   PubMed Web of Science ®Google Scholar
• Müller-Lissner S, Koch G, Talley NJ, Subjects global assessment of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. J Clin Epidemiol 2003;56:310-16.
   PubMed Web of Science ®Google Scholar
• Draft Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Food and Drug Administration, 2006.
   Google Scholar
• Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920-4.
   PubMed Web of Science ®Google Scholar
• Frank L, Kleinman L, Farup C, Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 1999;34:870-7.
   PubMed Web of Science ®Google Scholar
• Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain 2006;10:209-17.
   PubMed Web of Science ®Google Scholar
• Rome Foundation. Guidelines– Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis 2006;15:307-12.
   PubMedGoogle Scholar
• Nadstawek J, Leyendecker P, Hopp M, Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008;62:1159-67.
   PubMed Web of Science ®Google Scholar
• Vondrackova D, Leyendecker P, Meissner W, Analgesic efficacy and safety for oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008;9:1144-54.
   PubMed Web of Science ®Google Scholar
• Simpson KH, Leyendecker P, Hopp M, Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate to severe noncancer pain. Curr Med Res Opin 2008;24,3503-12.
   PubMed Web of Science ®Google Scholar
• Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
   Web of Science ®Google Scholar
• Hays RD, Anderson RT, Revicki DA. Assessing reliability and validity of measurement in clinical trials . In: Staquet MJ, Hays RD, Fayers PM , eds. Quality of Life Assessment in Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1998.
   Google Scholar
• Cohen J. Statistical power analyses for the behavioral sciences, 2nd edn. Hillsdale NJ: Lawrence Erlbaum, 1988.
   Google Scholar
• Deyo RA, Dieher P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991;12:142-58S.
   PubMedGoogle Scholar
• Myers JL., Well AD. Research Design and Statistical Analysis, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum, 2003:508.
   Google Scholar
• Mc Donald JH. Handbook of Biological Statistics. Baltimore, MD: Sparky House Publishing, 2008. [URL: http://udel.edu/∼mcdonald/statanovamodel.html ] Accessed April 2009.
   Google Scholar
• Hays RD, Revicki DA. Reliability and validity (including responsiveness). In: Fayers P, Hays RD , eds. Assessing Quality of Life in Clinical Trials, 2nd edn. New York: Oxford University Press, 2005.
   Google Scholar
• Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469-78.
   PubMed Web of Science ®Google Scholar
• Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999;52:861-73.
   PubMed Web of Science ®Google Scholar
• Connell AM, Hilton C, Irwine G, Variation in bowel habits in two population samples. Br Med J 1965;2:1095-9.
   PubMed Web of Science ®Google Scholar
• McMillan SC. Assessing and managing opioid-induced constipation in adults with cancer. Cancer Control 2004;11(Suppl 1):3-9.
   PubMedGoogle Scholar
• Müller-Lissner S, Beil W. Moderne Therapie mit Laxanzien. Bremen: UniMed Verlag, 2006.
   Google Scholar
• Sweeney MA. Constipation – diagnosis and treatment. Home Care Provid 1997;2:250-5.
   PubMedGoogle Scholar
• Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness or evaluative trials. Br Med J 1998;316:690-3
   PubMed Web of Science ®Google Scholar